Menu Back to Committee

Meet the Program Commitee for 2026!

Program Committee

  • Sabine  Haubenreisser, PhD, MSc
    Sabine Haubenreisser, PhD, MSc Principal Scientific Administrator, Stakeholders and Communication Division
    European Medicines Agency, Netherlands
  • Aimad  Torqui
    Aimad Torqui Head of Division European cooperation and veterinary affairs
    MEB, Netherlands
  • Dimitrios  Athanasiou, MBA
    Dimitrios Athanasiou, MBA Patient Advocate
    WORLD DUCHENNE ORGANIZATION (WDO) , MDA HELLAS, Greece
  • Seán  Byrne
    Seán Byrne Senior Manager Legal and Regulatory Affairs
    European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Belgium
  • Angelika  Joos, MPharm
    Angelika Joos, MPharm Executive Director, Global Regulatory Policy
    MSD, Belgium
  • João  Duarte, MPharm, MSc
    João Duarte, MPharm, MSc Vice President, Head of Global Regulatory Affairs Excellence
    Ipsen, France
  • Tim  Chesworth
    Tim Chesworth Senior Director Regulatory Affairs
    AstraZeneca, United Kingdom
  • Angela  Currie
    Angela Currie Head of New Product Introduction and Regulatory Intelligence, Operations Regulat
    AstraZeneca, United Kingdom
  • Teresa  Eastwood-Kiefer
    Teresa Eastwood-Kiefer Global Lead, Regulatory Submission Management
    Roche, Switzerland
  • Rüdiger  Faust, DrSc
    Rüdiger Faust, DrSc Global Regulatory Policy and Intelligence Lead
    UCB Biosciences GmbH, Germany
  • Chloe  Garay, PharmD
    Chloe Garay, PharmD Sr. Director, Global Regulatory Intelligence & Policy
    Eli Lilly and Company, United Kingdom
  • Pedro  Franco, PharmD, PhD, MS, MSc
    Pedro Franco, PharmD, PhD, MS, MSc Senior Director for Global Regulatory & Scientific Policy (GRASP)
    Merck Serono Limited, United Kingdom
  • Stuart  Finnie, DrSc, MS
    Stuart Finnie, DrSc, MS Senior Director, CMC RA Policy and Advocacy
    Gilead Sciences, United Kingdom
  • Lene  Kirstein, MPharm
    Lene Kirstein, MPharm Head of Regulatory Science & Strategy
    H. Lundbeck A/S, Denmark
  • Martin  O'Kane
    Martin O'Kane Regional Head RA EU Policy & Liaison
    Novartis Pharmaceuticals, United Kingdom
  • Susan M Sandler, RPh
    Susan M Sandler, RPh Director, Global Regulatory Policy and Intelligence
    Johnson & Johnson, United Kingdom
  • Jens-Ulrich  Stegmann, MD, RN
    Jens-Ulrich Stegmann, MD, RN Senior Vice President, Head Clinical Safety and Pharmacovigilance and EU QPPV
    GSK , Belgium
  • Jonathan  Sutch, PhD
    Jonathan Sutch, PhD Principal Medicinal Technical Specialist
    BSI Group, United Kingdom
  • Sarah  Vaughan
    Sarah Vaughan Head of Vigilance Operations
    Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
  • Gabriel  Westman, MD, PhD
    Gabriel Westman, MD, PhD Head of Artificial Intelligence
    Swedish Medical Products Agency, Sweden
Load More

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.